Market Capitalization (Millions $) |
3 |
Shares
Outstanding (Millions) |
7 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-13 |
Cash Flow (TTM) (Millions $) |
1 |
Capital Exp. (TTM) (Millions $) |
0 |
Palisade Bio Inc
Palisade Bio Inc is a biopharmaceutical company that focuses on the development and commercialization of novel therapies for patients with gastrointestinal (GI) diseases. The company's primary goal is to address the unmet medical needs in the GI space and improve the lives of patients suffering from these conditions. Palisade Bio Inc is committed to advancing innovative therapies through rigorous research and development, clinical trials, and collaboration with healthcare professionals. Their portfolio includes potential treatments for conditions like ulcerative colitis, Crohn's disease, and irritable bowel syndrome. The company aims to bring effective and safe therapies to patients worldwide and make a positive impact in the field of GI medicine.
Company Address: 7750 El Camino Real, Suite 2A Carlsbad 92009 CA
Company Phone Number: 704-4900 Stock Exchange / Ticker: NASDAQ PALI
PALI is expected to report next financial results on March 21, 2024. |
|
|